The canceled Nikola Badger
DUBAI, U.A.E, Nov. 25, 2020 /PRNewswire/ -- HBKiCare a pioneering developer of IoT (Internet of Things) software for remote health monitoring, announced today that it will sponsor the leading Middle East Telehealth Technologies Forum. HBKiCare was launched recently by Hamad Bin Khalifa Department of Projects (HBK DOP) from the United Arab Emirates (UAE) together with its partner, SURE Universal Ltd, a leading software developer from Israel specializing in remote patient monitoring.
With the COVID-19 driven tsunami in the telehealth sector, the Middle East Telehealth Technologies Forum brings together leading healthcare companies in the Middle East to share their experiences, lessons learned, and to discuss opportunities and digital health challenges.
Anwar Hussein, CEO of HBK DOP, stated: " We are proud to sponsor this Middle East Telehealth Technology forum and demonstrate a solution for COVID-19 that can benefit the health and well-being of the entire Middle East region."
SURE's CEO, Viktor Ariel, will give a keynote presentation about HBKiCare's remote outpatient IOT monitoring solution for COVID-19.
"We are excited to participate in this prestigious event and to speak about the importance of remote health monitoring during COVID-19 pandemic in our region," stated SURE's CEO, Dr. Ariel. "I am proud of our HBKiCare product and our partnership with HBK DOP, which is bringing together new solutions and forging new relationships between Israel and our regional neighbours in the Middle East."
HBKiCare, was the first joint product launch between an Israeli health-tech company and UAE firm following signing of the historic peace deal. The innovative product, powered by SURE's technology, provides a Universal Remote Healthcare IOT platform and home care kit enabling continuous outpatient monitoring of wellness with maximum flexibility and affordability.
Due to the COVID-19 pandemic, the number of patients that currently need care outnumbers the number of healthcare professionals. In addition, there is a threat of hospital acquired infections, which is a threat to both patients and medical practitioners. Telehealth addresses these challenges by enabling medical professionals to use early outpatient COVID-19 detection and monitoring with the help of new technology.
The HBKiCare platform uses inexpensive off-the-shelf wearable devices and SURE Universal's software IoT platform to monitor patients at home both before and after treatment for COVID-19. It provides continuous monitoring of vital signs, such as, body temperature, blood oxygen, respiratory rate, heart rate, and even ECG, which comprise an essential COVID-19 monitoring protocol. All the devices have FDA or CE Medical certification and the software delivers routine as well as smart AI-based recommendations to doctors regarding patients' medical conditions.
About HBK DOP
Sheikh Hamad bin Khalifa bin Mohammed Al Nahyan Department of Projects (HBK DOP) was founded by its Chairman, His Highness Sheikh Hamad bin Khalifa bin Mohammed Al Nahyan a member of the UAE ruling family to handle project investments and enter into JV partnerships with partners presenting viable and interesting projects with sustainability and job creation. His Highness Sheikh Hamad bin Khalifa bin Mohammed Al Nahyan is a seasoned business leader with a proven track record of success over the past two decades, across regions and including most segments of business. His leadership style is often described as visionary, innovative and inspirational.
For more information visit www.hbkdop.org
About Sure Universal
SURE Universal Ltd is a pioneering developer of IoT software for remote patient monitoring, addressing the critical and growing need for accessible healthcare services worldwide. SURE Universal Care is a complete solution suitable for inpatient hospital care, outpatient treatment by clinics and old age homes, as well as wellness and fitness tracking and family care at home. SURE Universal Care platform is based on international standards for IoT and medical care to guarantee device interoperability, data security, and user privacy. SURE Universal works closely with international partners in the US, China, UAE, Hong Kong, Singapore and other regions. The company was co-founded by seasoned technology entrepreneurs, Mr. Ray Stata and Dr. Viktor Ariel, and is headquartered in Ramat Gan, Israel.
For more information visit www.sureuniversal.com
Anwar HusseinGroup CEO,HBK Department of ProjectsTel: +firstname.lastname@example.org
Viktor ArielCEO,SURE UniversalTel: +email@example.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/hbkicare-sponsors-leading-middle-east-telehealth-technologies-forum-to-promote-remote-covid-19-healthcare-301180430.html
SOURCE SURE Universal and HBK Department of Projects
ICON plc, (NASDAQ: ICLR) a leading global provider of drug development and commercialisation services to the pharmaceutical, biotechnology and medical device industries today announced that it has been recognised in the 2020 Forbes List of America’s Best Employers for Women for the second consecutive year. Forbes collaborated with market research firm Statista, surveying 75,000 Americans, including 45,000 women, working for businesses that employ more than 1,000 workers. The respondents spanned 31 industries and were asked to share their opinions on a series of statements about their respective employers’ culture, opportunities for career development, image, working conditions, salary and diversity.
"We’re delighted to be recognised in the Forbes list of Best Employers for Women for the second consecutive year”, commented Joe Cronin, Chief Human Resources Officer, ICON. "As the only CRO named in 2020, we’re proud of our unique culture at Icon and the resilience of our teams during challenging times. We are committed to ensuring that all of our employees are able to build fulfilling and successful careers at ICON and that we create an inclusive workplace where every employee can bring their best and authentic selves to work every day in pursuit of our mission to accelerate the development of medicines that improve and save patient lives.”
Earlier this year ICON was ranked in Forbes list of 2020 Best Employers for Diversity. A full list of ICON’s industry awards can be viewed here.
About ICON plc
ICON plc is a global provider of drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device and government and public health organisations. The company specialises in the strategic development, management and analysis of programs that support clinical development - from compound selection to Phase I-IV clinical studies. With headquarters in Dublin, Ireland, ICON currently operates from 94 locations in 40 countries and has approximately 15,150 employees as of June 30, 2020.
Further information is available at www.iconplc.com.
This press release contains forward-looking statements. These statements are based on management's current expectations and information currently available, including current economic and industry conditions. These statements are not guarantees of future performance or actual results, and actual results, developments and business decisions may differ from those stated in this press release. The forward-looking statements are subject to future events, risks, uncertainties and other factors that could cause actual results to differ materially from those projected in the statements, including, but not limited to, the ability to enter into new contracts, maintain client relationships, manage the opening of new offices and offering of new services, the integration of new business mergers and acquisitions, as well as economic and global market conditions and other risks and uncertainties detailed from time to time in SEC reports filed by ICON, all of which are difficult to predict and some of which are beyond our control. For these reasons, you should not place undue reliance on these forward-looking statements when making investment decisions. The word "expected" and variations of such words and similar expressions are intended to identify forward-looking statements. Forward-looking statements are only as of the date they are made and we do not undertake any obligation to update publicly any forward-looking statement, either as a result of new information, future events or otherwise. More information about the risks and uncertainties relating to these forward-looking statements may be found in SEC reports filed by ICON, including its Form 20-F, F-1, S-8 and F-3, which are available on the SEC's website at https://www.sec.gov.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200821005154/en/